COMMUNIQUÉS West-GlobeNewswire

Surgery Partners, Inc. Announces Add-On Senior Notes Offering
11/12/2025
BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery [...]
Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program
11/12/2025
Ra’anana, Israel, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announced new results [...]
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio
11/12/2025
Authorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection • Portfolio includes tests for colorectal disease, breast self exam, prostate disease, kidney disease, and H. pylori infection [...]
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)
11/12/2025
Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HIT It is the first and only potent, highly selective inhibitor of human 12-LOX in clinical testing, distinguishing [...]
60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026
11/12/2025
6-month commercial pilot demonstrated increasing demand among prescribers Expansion plan includes doubling the number of sales reps, a new GoodRx partnership, and enhanced digital marketing campaign Additional clinical [...]
Ophirex Announces Business Update: Advances Toward Food and Drug Administration (FDA) Approval for Varespladib as Novel Oral Snakebite Treatment
11/12/2025
Company announces agreement with FDA on human approval pathway based on Animal Rule Varespladib has received FDA MUMS designation for treatment of snakebite in dogs Animal health leader Aaron Schacht joins Board of [...]
Stryker declares an $0.88 per share quarterly dividend
11/12/2025
Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable January 30, 2026, to shareholders of record at [...]
ViroMissile Announces First-in-Human Phase I Trial of IDOV-Immune for Advanced Solid Tumors
11/12/2025
Study examines the safety and early efficacy of an oncolytic virus via a single intravenous dose SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- ViroMissile , Inc., a cancer immunotherapy company pioneering the IDOV™ ( [...]
PatchMD Launches New Dopamine Support Patch for Natural Mood and Focus Support
11/12/2025
Original Vitamin Patch Pioneer Introduces Comprehensive Dopamine Precursor Formula Backed by Clinical Research Las Vegas, NV, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Introductory Pricing: $19.95 with 30% December Discount [...]
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial
11/12/2025
Antigen spreading was evaluated in a subset of Phase 2 patients to assess the ability of ELI-002 7P to broaden immune responses to personalized tumor neoantigens not present in the targeted immunotherapy 87% (13/15) of [...]
MD Logic Health & Well Minerals Launch Pure Whole Food Vitamin C, a Premium, 100% Natural Vitamin C Supplement Sourced Exclusively from Organic Fruit
11/12/2025
Miami, FL, Dec. 11, 2025 (GLOBE NEWSWIRE) -- In an era where consumers are increasingly conscious of the origins and quality of their nutritional supplements, Well Minerals x MD Logic Health® 's new collaboration [...]
Parsley Health Launches BYO Labs Review: The First Clinician-Led Service Turning Outside Lab Data Into Personalized Health Plans
11/12/2025
New York, New York, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Parsley Health , the nationally recognized functional medicine platform known for combining advanced diagnostics with root-cause medical care, today announced the [...]
Graham and Courtney Rahal Foundation Donates $225,000 to SoldierStrong Through Vino for Vets Event
11/12/2025
NAPA VALLEY, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Graham & Courtney Rahal Foundation (GCRF) hosted its fourth-annual Vino For Vets powered by DropLight fundraiser in October, donating $225,000 to benefit [...]
Eclipse Energy Announces Collaborative Partnership with Weatherford Accelerating Commercialization of Subsurface Clean Energy Technologies
11/12/2025
HOUSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Eclipse Energy today announced a collaborative partnership with Weatherford International plc (NASDAQ: WFRD) that includes a capital investment from Weatherford to accelerate [...]
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
11/12/2025
No Stockholder Action Required at this Time DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company” or “PetMeds”), today [...]
Acentra Health Names Patty Obermaier as Chief Growth Officer
11/12/2025
Proven healthcare leader to drive growth and product innovation in support of the company’s mission to accelerate better health outcomes MCLEAN, Va., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology and [...]
Matisse Pharmaceuticals receives INN isupartob sodium recognizing first-in-class drug status for M6229
11/12/2025
Geleen, December 11, 2025 Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, today announced that Matisse’s lead compound M6229, has received the [...]
Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation
11/12/2025
Restructuring Supports RYTELO ® U.S. Commercial Strategy and Investment in Clinical Development Expected to Reduce 2026 Projected Operating Expenses FOSTER CITY, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Geron [...]
Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026
11/12/2025
EMBOLD data to serve as basis of efficacy and safety following discussion with the FDA BOSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical [...]

Pages